Fig 2. Percentage of eculizumab recipients receiving antibiotics for ≥50% of the risk period by year of starting eculizumab treatment, IBM Marketscan Commercial Database, 2007–2017.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.